Xwell (XWEL) Free Cash Flow Growth (1y) (2011 - 2026)
Xwell (XWEL) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 16.06% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -173.96% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 87.85% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 23.29% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 112.68% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -21.08% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 33.01% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -42.16% |
| 10 | Xwell | 8.44 Mn | -3.33 Mn | 2.95 Mn | -43.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -43.02% |
| Mar 31, 2026 | -8.47% |
| Dec 31, 2025 | 85.74% |
| Sep 30, 2025 | -21.01% |
| Jun 30, 2025 | -311.43% |
| Mar 31, 2025 | -15.83% |
| Dec 31, 2024 | -51.28% |
| Sep 30, 2024 | 17.88% |
| Jun 30, 2024 | 69.20% |
| Mar 31, 2024 | 45.34% |
| Dec 31, 2023 | 53.46% |
| Sep 30, 2023 | 55.74% |
| Jun 30, 2023 | 72.05% |
| Mar 31, 2023 | -111.74% |
| Dec 31, 2022 | -207.00% |
| Sep 30, 2022 | -244.95% |
| Jun 30, 2022 | -1,815.03% |
| Mar 31, 2022 | 23.44% |
| Dec 31, 2021 | 177.74% |
| Sep 30, 2021 | 204.32% |